About Linkage Biosciences
Linkage Biosciences is a company based in San Francisco (United States) founded in 2004 was acquired by Thermo Fisher Scientific in July 2017. Linkage Biosciences has raised $12.64 million across 7 funding rounds from investors including Thermo Fisher Scientific, Big Sky Partners and GHC Partners. The company has 34 employees as of December 31, 2016. Linkage Biosciences offers products and services including LinkSeq PCR Typing Kits, LinkSeq HLA Typing Kits, LinkSeq KIR Typing Kits, and LinkSeq Wipe Test. Linkage Biosciences operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter San Francisco, United States
- Employees 34 as on 31 Dec, 2016
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.64 M (USD)
in 7 rounds
-
Latest Funding Round
$2 M (USD), Series B
May 08, 2013
-
Investors
Thermo Fisher Scientific
& 4 more
-
Employee Count
34
as on Dec 31, 2016
-
Acquired by
Thermo Fisher Scientific
(Jul 11, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Linkage Biosciences
Linkage Biosciences offers a comprehensive portfolio of products and services, including LinkSeq PCR Typing Kits, LinkSeq HLA Typing Kits, LinkSeq KIR Typing Kits, and LinkSeq Wipe Test.
Rapid PCR kits for contamination-free genotyping in labs.
Kits for low resolution typing of HLA loci.
Tools for typing KIR genes and pseudogenes.
Test for detecting DNA contamination in labs.
Funding Insights of Linkage Biosciences
Linkage Biosciences has successfully raised a total of $12.64M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linkage Biosciences
Linkage Biosciences has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Big Sky Partners and GHC Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth equity capital is provided by GHC Partners for industrial innovation.
|
Locked | Locked | Locked | |
|
Fisher Capital is engaged in private equity and real estate investments.
|
Locked | Locked | Locked | |
|
Early-stage investments in US tech and energy firms are targeted.
|
Locked | Locked | Locked |
Investor details for Linkage Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linkage Biosciences
Investment portfolio details for Linkage Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linkage Biosciences
Detailed financials for Linkage Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linkage Biosciences Comparisons
Peer comparison for Linkage Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linkage Biosciences
Linkage Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
Detailed competitors of Linkage Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linkage Biosciences
Complete news archive for Linkage Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linkage Biosciences
Linkage Biosciences was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Linkage Biosciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Linkage Biosciences is a funded company, having raised a total of $12.64M across 7 funding rounds to date.
As of Dec 31, 2016, the latest employee count at Linkage Biosciences is 34.
Founded in 2004 and based in San Francisco, United States, Linkage Biosciences operates in the molecular diagnostics sector. In vitro diagnostic kits are developed by the company for transplant patients, with emphasis on donor matching and monitoring processes. The product lineup encompasses HLA typing, HPA typing, wipe testing, and KIR genotyping solutions.
Linkage Biosciences's top competitors include Qiagen, Parse Biosciences and NuProbe.
Linkage Biosciences offers LinkSeq PCR Typing Kits, LinkSeq HLA Typing Kits, LinkSeq KIR Typing Kits, and LinkSeq Wipe Test.
Linkage Biosciences has 5 investors. Key investors include Thermo Fisher Scientific, Big Sky Partners, GHC Partners, Fisher Capital, and James R. Fisher.